People · Operator
Named in public records as an officer, director or promoter · active 2012–2025 · Other, Healthtech, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Bioventrix Inc | — | Other | Series B | $191.3M | $20.8M | 2012 |
| Conformal Medical, Inc. | — | Healthtech | Series C | $145.1M | $200.5M | 2023 |
| MIVI Neuroscience, Inc. | — | Other Health Care | Series C | $67.4M | $4.3M | 2017 |
George Fazio at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside George Fazio on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| BIHUA CHEN | 1 | 14 |
| Frederic Moll | 1 | 10 |
| Kenneth Miller | 1 | 8 |
| FRED MOLL | 1 | 8 |
| Scott Ward | 1 | 7 |
| Michael Taglich | 1 | 7 |
| Robert Stern | 1 | 6 |
| Arthur Bertolero | 1 | 5 |
| Ken Miller | 1 | 5 |
| Maurice Ferre | 1 | 5 |
| Christopher Dewey | 1 | 4 |
| Joshua S. Phillips | 1 | 4 |
| Aaron Kaplan | 1 | 3 |
| Robert Taglich | 1 | 3 |
| Steven Healy | 1 | 3 |
| James Reinstein | 1 | 3 |
| WILLIAM ABBOTT | 1 | 3 |
| James McCollum | 1 | 3 |
| Christopher Geyen | 1 | 3 |
| Taylor Whitman | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.